Angiotensin I
EmergingAngiotensin I is the inactive precursor in the renin-angiotensin pathway, the conceptual basis for two major blood pressure drug classes.
Angiotensin I is a stepping-stone hormone that gets converted into the more active angiotensin II. It isn't tested directly, but understanding this chemical pathway is exactly why ACE inhibitor and ARB blood pressure medications work the way they do.
Angiotensin I is the inactive precursor peptide cleaved by angiotensin-converting enzyme (ACE, discussed much earlier) to form angiotensin II, the active hormone that raises blood pressure and drives sodium retention.
Angiotensin I itself isn't a marker of any specific disease state; its clinical relevance is entirely as an intermediate step in the renin-angiotensin-aldosterone system pathway, connecting the renin discussion (much earlier) to the ACE discussion.
Not routinely measured as a standalone clinical test; the pathway's key clinical tests are renin and aldosterone (discussed earlier), with angiotensin I functioning as the conceptual bridge between renin's action and ACE's action in the cascade.
Understanding this pathway is the basis for both major blood pressure medication classes: ACE inhibitors (which block the conversion of angiotensin I to angiotensin II) and angiotensin receptor blockers/ARBs (which block angiotensin II's effects downstream), together representing some of the most widely prescribed medications worldwide.
Not directly measured clinically; its relevance is entirely as an intermediate step connecting renin and ACE activity.
- General physiology/pharmacology reference literature on the renin-angiotensin-aldosterone system pathway.